stock delisting Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing. T2 Biosystems Regains Compliance With Nasdaq Listing Requirements In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days. T2 Biosystems Receives Nasdaq Warning Letter The Lexington, Massachusetts-based company also terminated a purchase agreement and raised the amount in it may raise in a public offering of its common stock to $95. Genetic Technologies Receives Nasdaq Delisting Notification The company will not be allowed to submit another plan for meeting the Nasdaq's listing requirements. Nasdaq Warns Biocept Over Listing Requirement The firm has a 180-day grace period in which to regain compliance, by maintaining a $1.00 minimum closing bid price for at least 10 consecutive business days. Aug 23, 2019 OpGen Stock Non-Compliant With Nasdaq Listing Requirement Jul 8, 2019 Nasdaq Warns Co-Diagnostics Over Listing Requirement Apr 26, 2019 Precipio to Effect 1-for-15 Reverse Stock Split Jan 18, 2019 NantHealth Receives Nasdaq Delisting Notice Sep 28, 2018 Precipio Gets Extension to Meet Nasdaq Listing Requirement Apr 2, 2018 Precipio Out of Compliance With Nasdaq Listing Requirement Jan 17, 2018 OpGen to Execute 1-for-25 Reverse Stock Split Dec 27, 2017 OpGen to Meet With Nasdaq Panel to Stave Off Delisting Aug 4, 2017 HTG Molecular Out of Compliance with Nasdaq Listing Requirement Jul 24, 2017 Genetic Technologies Facing Nasdaq Delisting Jun 22, 2017 OpGen Warned by Nasdaq of Non-Compliance May 15, 2017 OpGen Falls Short on Nasdaq Listing Requirement Apr 13, 2017 Interpace Diagnostics Regains Nasdaq Compliance Feb 21, 2017 HTG Molecular Appeals Delisting Determination by Nasdaq Dec 28, 2016 Interpace Effecting a 1-for-10 Reverse Stock Split Nov 30, 2016 Interpace Diagnostics Faces Nasdaq Delisting Nov 28, 2016 Signal Genetics Regains Compliance With Nasdaq Listing Requirement Oct 10, 2016 Great Basin Shares to Be Delisted From Nasdaq Sep 7, 2016 Great Basin Scientific Receives Nasdaq Delisting Warning Jun 24, 2016 Great Basin to Stay Listed on Nasdaq Load More Breaking News FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.